Sign In
Buy NDAQ
$82.49
-0.120 (-0.145%)
At Close: Jun 23, 2026
A Nasdaq Bull Market Is Coming: 3 Tariff-Resistant Growth Stocks to Confidently Buy Right Now
05:27am, Wednesday, 14'th May 2025
The Nasdaq Composite (^IXIC 1.61%) technology index was down by as much as 24% from its all-time high in April, placing it in a bear market. The sell-off was triggered by President Donald Trump's "Lib
Nasdaq Rally: My 3 Favorite Stocks to Buy Now
05:15am, Wednesday, 14'th May 2025
The three major benchmarks soared on Monday as the U.S. announced an initial import tariff agreement with China. This was a game-changing moment for investors as concerns about President Donald Trump'
Green Notes of AKROPOLIS GROUP, UAB are planned to be listed on Euronext Dublin and Nasdaq Vilnius stock exchanges
01:55am, Wednesday, 14'th May 2025
NOT FOR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, THE UNITED STATES OR TO ANY U.S. PERSON, OR IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN ANY OTHER JURISDICTION WHERE IT
Stock and crypto trading site eToro prices IPO at $52 per share ahead of Nasdaq debut
07:31pm, Tuesday, 13'th May 2025
Israel-based stock brokerage platform eToro said it has priced shares at $52 for its IPO, above its expected range of $46 to $50. The retail trading platform filed for an IPO in March, but as tariff u
Stock Market Rally Shows No Quit; Nasdaq Jumps On Nvidia News As Palantir Joins Breakout Ranks
05:38pm, Tuesday, 13'th May 2025
The stock market rally continued unabated Tuesday, helped by a big gains for large cap techs like Palantir, Nvidia and Broadcom.
Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Tuesday, 13'th May 2025
SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic he
S&P500 and Nasdaq: Soft CPI Boosts Nvidia and Coinbase; UNH Falls
01:23pm, Tuesday, 13'th May 2025
Easing CPI and a U.S.-China tariff pause push S&P500 and Nasdaq higher, while UnitedHealth drags Dow. Tech stocks and Coinbase lead US stock market gains.
Nasdaq Rises Over 1%; Under Armour Posts Strong Q4 Sales
10:33am, Tuesday, 13'th May 2025
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 250 points on Monday.
Odyssey Marine Exploration Reports Q1 2025 Results, Regains Nasdaq Compliance, and Announces New Capital Infusion
08:00am, Tuesday, 13'th May 2025
TAMPA, Fla.--(BUSINESS WIRE)---- $OMEX--Odyssey Marine Exploration, Inc. (NASDAQ: OMEX), an ocean exploration pioneer engaged in the discovery, development and extraction of critical minerals that pro
An Innovative Way To Hedge Exposure To The Nasdaq-100
06:37am, Tuesday, 13'th May 2025
These strategies seek to mitigate market risk while participating in gains by combining long equity positions with hedging instruments such as options. Invesco QQQ Hedged Advantage ETF (QQHG) is desig
Perimeter Acquisition Corp. I Announces Pricing of Upsized $210,000,000 Initial Public Offering
05:10pm, Monday, 12'th May 2025
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Perimeter Acquisition Corp. I (Nasdaq: PMTRU) (the “Company”), a special purpose acquisition company, today announced the pricing of its upsized initial
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:00pm, Monday, 12'th May 2025
SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on May 10, 2025, the Compensation Committee of its Board of Directors granted inducement equity grants to six
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:00pm, Monday, 12'th May 2025
BEDFORD, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis (“OA”) pain management and regenerative solutions spaces focused o
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:38pm, Monday, 12'th May 2025
PHILADELPHIA, May 12, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispe
Hepion Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq
04:30pm, Monday, 12'th May 2025
MORRISTOWN, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that had been developing a treatment for non-alcoholic steatoh
